Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

- PMLiVE

J&J could launch its single-dose COVID-19 vaccine in March

Chief scientific officer Paul Stoffels said J&J is aiming for one billion doses in 2021

- PMLiVE

Nucleus Global announces a trio of promotions

Dan Bridges is appointed as new chief executive officer

- PMLiVE

AstraZeneca’s focus on diagnosing and managing chronic kidney disease

People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care

The Lucid Group Futures Academy welcomes its 2021 cohort

This week Lucid welcomed its newest cohort of graduates onto the 2021 Futures Academy programme. The programme provides graduates with a 12-month structured medical writing training programme. It’s a chance...

Lucid Group Communications Limited

- PMLiVE

UK biotech Synairgen treats first patient in phase 3 COVID-19 trial

SNG001 delivers an inhaled formulation of Interferon-beta-1a directly to the lungs

- PMLiVE

Sinovac’s COVID-19 vaccine demonstrates 50.4% efficacy in Brazilian trial data

Updated data is lower than previously reported efficacy rate

- PMLiVE

Merck wins speedy FDA review for 15-valent pneumococcal vaccine

Pfizer's rival 20-valent candidate was granted priority review in December 2020

- PMLiVE

Pfizer makes first investments through ‘breakthrough growth’ fund

Pharma giant invested $120m in four biotechs in the second half of 2020

- PMLiVE

AZ seeks EU approval for its Oxford University-partnered COVID-19 vaccine

CHMP could reach a decision on opinion by 29 January

- PMLiVE

Publicis Health appoints Kara Dugan as president of Razorfish Health

Dugan has spent over a decade at Publicis Health

- PMLiVE

BioNTech boosts COVID-19 vaccine capacity and aims to deliver 2 billion doses in 2021

Company will also publish data on vaccine's efficacy against new variants soon

- PMLiVE

Lilly’s anti-amyloid antibody donanemab renews Alzheimer’s hopes

Drug demonstrated a 'significant' slowing of cognitive decline

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links